Gary
Landreth
PhD
Location
Bloomington, IN, USA
Current Organization
Indiana University
Other Grants Featuring This Grantee
Alzheimer's Disease Research
Is the Niacin Receptor HCAR2 Protective in Alzheimer's Disease?
Active Dates
July 01, 2022 - June 30, 2024
Principal Investigator
Miguel Moutinho, PharmD, PhD
Current Organization
Indiana University
Alzheimer's Disease Research
RXR: A Therapeutic Target in Neurodegenerative Disease
Active Dates
July 01, 2011 - June 30, 2013
Principal Investigator
Gary Landreth, PhD
Current Organization
Indiana University
Alzheimer's Disease Research
PPAR-Gamma as a Therapeutic Target in Alzheimer's Disease
Active Dates
April 01, 2007 - March 31, 2008
Principal Investigator
Gary Landreth, PhD
Current Organization
Indiana University